159 related articles for article (PubMed ID: 33752142)
1. Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin.
Maeyama JI; Iho S; Suzuki F; Hayashi D; Yamamoto T; Yamazaki T; Goto Y; Ozeki Y; Matsumoto S; Yamamoto S
Tuberculosis (Edinb); 2021 May; 128():102067. PubMed ID: 33752142
[TBL] [Abstract][Full Text] [Related]
2. Recombinant mycobacterial DNA-binding protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vaccinated individuals' blood cells in combination with CpG-DNA.
Ozeki Y; Yokoyama A; Nishiyama A; Yoshida Y; Ohara Y; Mashima T; Tomiyama C; Shaban AK; Takeishi A; Osada-Oka M; Yamaguchi T; Tateishi Y; Maeyama JI; Hakamata M; Moro H; Kikuchi T; Hayashi D; Suzuki F; Yamamoto T; Iho S; Katahira M; Yamamoto S; Matsumoto S
Sci Rep; 2024 Apr; 14(1):9141. PubMed ID: 38644371
[TBL] [Abstract][Full Text] [Related]
3. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice.
Matsumoto S; Matsumoto M; Umemori K; Ozeki Y; Furugen M; Tatsuo T; Hirayama Y; Yamamoto S; Yamada T; Kobayashi K
J Immunol; 2005 Jul; 175(1):441-9. PubMed ID: 15972678
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.
Wedlock DN; Denis M; Skinner MA; Koach J; de Lisle GW; Vordermeier HM; Hewinson RG; van Drunen Littel-van den Hurk S; Babiuk LA; Hecker R; Buddle BM
Infect Immun; 2005 Jun; 73(6):3540-6. PubMed ID: 15908383
[TBL] [Abstract][Full Text] [Related]
5. A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
Dey B; Jain R; Gupta UD; Katoch VM; Ramanathan VD; Tyagi AK
PLoS One; 2011; 6(8):e23360. PubMed ID: 21858087
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.
da Fonseca DM; Silva CL; Wowk PF; Paula MO; Ramos SG; Horn C; Marchal G; Bonato VL
Infect Immun; 2009 Dec; 77(12):5311-21. PubMed ID: 19752029
[TBL] [Abstract][Full Text] [Related]
7. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
Front Immunol; 2018; 9():2371. PubMed ID: 30386336
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
9. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.
Mollenkopf HJ; Grode L; Mattow J; Stein M; Mann P; Knapp B; Ulmer J; Kaufmann SH
Infect Immun; 2004 Nov; 72(11):6471-9. PubMed ID: 15501778
[TBL] [Abstract][Full Text] [Related]
10. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
[TBL] [Abstract][Full Text] [Related]
11. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
12. Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.
Komine-Aizawa S; Yamazaki T; Yamazaki T; Hattori S; Miyamoto Y; Yamamoto N; Haga S; Sugitani M; Honda M; Hayakawa S; Yamamoto S
Clin Vaccine Immunol; 2010 Oct; 17(10):1500-6. PubMed ID: 20685935
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis.
Prados-Rosales R; Carreño LJ; Batista-Gonzalez A; Baena A; Venkataswamy MM; Xu J; Yu X; Wallstrom G; Magee DM; LaBaer J; Achkar JM; Jacobs WR; Chan J; Porcelli SA; Casadevall A
mBio; 2014 Sep; 5(5):e01921-14. PubMed ID: 25271291
[TBL] [Abstract][Full Text] [Related]
16. Inactivated
Kuczkowska K; Copland A; Øverland L; Mathiesen G; Tran AC; Paul MJ; Eijsink VGH; Reljic R
Front Immunol; 2019; 10():1588. PubMed ID: 31354727
[TBL] [Abstract][Full Text] [Related]
17. Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
Tkachuk AP; Gushchin VA; Potapov VD; Demidenko AV; Lunin VG; Gintsburg AL
PLoS One; 2017; 12(4):e0176784. PubMed ID: 28453555
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis.
Saqib M; Khatri R; Singh B; Gupta A; Kumar A; Bhaskar S
Tuberculosis (Edinb); 2016 Dec; 101():164-173. PubMed ID: 27865389
[TBL] [Abstract][Full Text] [Related]
20. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
